Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Depreciation & Amortization (CF) (2021 - 2025)

Historic Depreciation & Amortization (CF) for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to $21807.0.

  • Verrica Pharmaceuticals' Depreciation & Amortization (CF) fell 7819.3% to $21807.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $208807.0, marking a year-over-year decrease of 5420.9%. This contributed to the annual value of $342000.0 for FY2024, which is 3547.17% down from last year.
  • According to the latest figures from Q3 2025, Verrica Pharmaceuticals' Depreciation & Amortization (CF) is $21807.0, which was down 7819.3% from $45000.0 recorded in Q2 2025.
  • Verrica Pharmaceuticals' Depreciation & Amortization (CF)'s 5-year high stood at $177000.0 during Q4 2022, with a 5-year trough of $11000.0 in Q1 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $100000.0 (2023), whereas its average is $91568.8.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first skyrocketed by 79090.91% in 2022, then crashed by 7819.3% in 2025.
  • Quarter analysis of 5 years shows Verrica Pharmaceuticals' Depreciation & Amortization (CF) stood at $142000.0 in 2021, then grew by 24.65% to $177000.0 in 2022, then fell by 26.55% to $130000.0 in 2023, then crashed by 67.69% to $42000.0 in 2024, then tumbled by 48.08% to $21807.0 in 2025.
  • Its last three reported values are $21807.0 in Q3 2025, $45000.0 for Q2 2025, and $100000.0 during Q1 2025.